Literature DB >> 24703509

Neuregulin-3 in the mouse medial prefrontal cortex regulates impulsive action.

Maarten Loos1, Thomas Mueller2, Yvonne Gouwenberg3, Ruud Wijnands1, Rolinka J van der Loo1, Carmen Birchmeier2, August B Smit3, Sabine Spijker4.   

Abstract

BACKGROUND: A deficit in impulse control is a prominent, heritable symptom in several psychiatric disorders, such as addiction, attention-deficit/hyperactivity disorder, and schizophrenia. Here, we aimed to identify genes regulating impulsivity, specifically of impulsive action, in mice.
METHODS: Using the widely used 5-choice serial reaction time task, we measured impulsive action in 1) a panel of 41 BXD recombinant inbred strains of mice (n = 13.7 ± .8 per strain; n = 654 total) to detect underlying genetic loci; 2) congenic mice (n = 23) to replicate the identified locus; 3) mice overexpressing the Nrg3 candidate gene in the medial prefrontal cortex (n = 21); and 4) a Nrg3 loss-of-function mutant (n = 59) to functionally implicate the Nrg3 candidate gene in impulsivity.
RESULTS: Genetic mapping of impulsive action in the BXD panel identified a locus on chromosome 14 (34.5-41.4 Mb), syntenic with the human 10q22-q23 schizophrenia-susceptibility locus. Congenic mice carrying the impulsivity locus (Impu1) confirmed its influence on impulsive action. Increased impulsivity was associated with increased Nrg3 gene expression in the medial prefrontal cortex (mPFC). Viral overexpression of Nrg3 in the mPFC increased impulsivity, whereas a constitutive Nrg3 loss-of-function mutation decreased it.
CONCLUSIONS: The causal relation between Nrg3 expression in the mPFC and level of impulsive action shown here provides a mechanism by which polymorphism in NRG3 in humans contributes to a specific cognitive deficit seen in several psychiatric diseases, such as addiction, attention-deficit/hyperactivity disorder, and schizophrenia.
Copyright © 2014 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5CSRTT; Behavior; Erbb4; impulsivity; inhibitory control; neuregulin

Mesh:

Substances:

Year:  2014        PMID: 24703509     DOI: 10.1016/j.biopsych.2014.02.011

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  33 in total

Review 1.  Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.

Authors:  Miranda L Fisher; Anu Loukola; Jaakko Kaprio; Jill R Turner
Journal:  Int Rev Neurobiol       Date:  2015-09-16       Impact factor: 3.230

2.  Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex.

Authors:  Ya-Nan Wang; Dwight Figueiredo; Xiang-Dong Sun; Zhao-Qi Dong; Wen-Bing Chen; Wan-Peng Cui; Fang Liu; Hong-Sheng Wang; Hai-Wen Li; Heath Robinson; Er-Kang Fei; Bing-Xing Pan; Bao-Ming Li; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

3.  The Extracellular Matrix Protein Brevican Limits Time-Dependent Enhancement of Cocaine Conditioned Place Preference.

Authors:  Bart R Lubbers; Mariana R Matos; Annemarie Horn; Esther Visser; Rolinka C Van der Loo; Yvonne Gouwenberg; Gideon F Meerhoff; Renato Frischknecht; Constanze I Seidenbecher; August B Smit; Sabine Spijker; Michel C van den Oever
Journal:  Neuropsychopharmacology       Date:  2015-12-29       Impact factor: 7.853

4.  Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.

Authors:  Clare Paterson; Yanhong Wang; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2016-10-24       Impact factor: 18.112

5.  Neuregulin and ErbB expression is regulated by development and sensory experience in mouse visual cortex.

Authors:  Steven F Grieco; Gina Wang; Ananya Mahapatra; Cary Lai; Todd C Holmes; Xiangmin Xu
Journal:  J Comp Neurol       Date:  2019-09-18       Impact factor: 3.215

6.  Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges.

Authors:  Zackary A Cope; Adam L Halberstadt; Jordy van Enkhuizen; Aaron D Flynn; Michelle Breier; Neal R Swerdlow; Mark A Geyer; Jared W Young
Journal:  Psychopharmacology (Berl)       Date:  2016-08-17       Impact factor: 4.530

Review 7.  Neuregulin 3 and its roles in schizophrenia risk and presentation.

Authors:  Dimitrios Avramopoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-29       Impact factor: 3.568

8.  Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.

Authors:  Detlef Vullhorst; Tanveer Ahmad; Irina Karavanova; Carolyn Keating; Andres Buonanno
Journal:  J Neurosci       Date:  2017-04-21       Impact factor: 6.167

Review 9.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

10.  Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition.

Authors:  Luyi Zhou; Miranda L Fisher; Robert D Cole; Thomas J Gould; Vinay Parikh; Pavel I Ortinski; Jill R Turner
Journal:  Neuropsychopharmacology       Date:  2017-11-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.